Kenya raises $ 130 million from the World Bank for COVID vaccines

A health worker gives a man a dose of AstraZeneca’s coronavirus disease (COVID-19) vaccine on April 8, 2021 at Ruaraka Uhai Neema Hospital in Nairobi, Kenya. REUTERS / Baz Ratner

NAIROBI, June 29 (Reuters) – Kenya has secured $ 130 million in additional funding from the World Bank to help purchase vaccines to fight the COVID-19 pandemic, the bank said Tuesday.

Like other countries across the continent, the East African nation has been hit by deadly waves of COVID-19 infections this year, forcing it to reinstate strict, partial lockdown measures.

“This additional funding comes at a critical time when the Kenyan government is making a concerted effort to contain the rising cases of COVID-19 infections,” said Keith Hansen, World Bank country director in Kenya.

The funding will help Kenya purchase vaccines through a dedicated African Union facility and through COVAX, the global program for the fair distribution of vaccines.

The funds will provide the government with “a flexible approach to selecting a portfolio of vaccines that best fits local capacities, delivery times and vaccine approvals,” said Jane Chuma, senior health economist at the World Bank.

The money will also be used to strengthen Kenya’s cold chain facilities for vaccine storage, health worker training, and other related activities.

Reporting by Duncan Miriri Editing by Mark Potter

Our Standards: The Thomson Reuters Trust Principles.

About Sonia Martinez

Check Also

Insights from the world: The Chinese-built modern railway in Kenya is praised for its green ethos

When construction of the 480km Mombasa-Nairobi Standard Gauge Railway (SGR) began in 2014, Ali Mohamed …

Leave a Reply

Your email address will not be published.